Last reviewed · How we verify
Current HAART regimen
Current HAART regimen is a Small molecule drug developed by Gilead Sciences. It is currently FDA-approved.
Current HAART (Highly Active Antiretroviral Therapy) regimens often involve the use of Raltegravir, a medication that targets the HIV virus, in combination with other treatments such as boosted protease inhibitors. This combination is used to manage conditions like HIV infections, AIDS, and pediatric HIV, as seen in clinical trials such as the SPIRAL study.
At a glance
| Generic name | Current HAART regimen |
|---|---|
| Sponsor | Gilead Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment (PHASE4)
- Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral Suppression (NA)
- Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens (PHASE4)
- Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r) (NA)
- Efficacy of Neuro-HAART in Patients With HIV
- Peripheral Body Fat Distribution After Switching Zidovudine and Lamivudine to Truvada (PHASE4)
- Safety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral Therapy (PHASE3)
- Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Current HAART regimen CI brief — competitive landscape report
- Current HAART regimen updates RSS · CI watch RSS
- Gilead Sciences portfolio CI
Frequently asked questions about Current HAART regimen
What is Current HAART regimen?
Who makes Current HAART regimen?
What development phase is Current HAART regimen in?
Related
- Manufacturer: Gilead Sciences — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing